Kurum Yazarı "Çakır, Aslı" WoS İndeksli Yayınlar Koleksiyonu İçin Listeleme
-
Adult case series of extramedullary relapsing acute myeloid leukemia (AML) after allogeneic stem cell transplantation in whom a rapid response and a reasonably long remission could be achieved with gemtuzumab ozogamycin (GO)
Sevindik, Ömür Gökmen; Gemici, Aliihsan; Usta, Furkan Selim; Çakır, Aslı; Sadri, Sevil; Bekoz, Hüseyin; Sargın, Fatma Deniz (The American Society of Hematology, 2019)Gemtuzumab Ozogamycin (GO) is a drug conjugated monoclonal antibody which targets CD33 an antigen highly expressed on the surface of AML blasts. GO is approved for the treatment of both newly-diagnosed and relapsed AML. ... -
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: The PANDA challenge
Bulten, Wouter; Kartasalo, Kimmo; Chen, Po-Hsuan Cameron; Ström, Peter; Pinckaers, Hans; Nagpal, Kunal; Cai, Yuannan; Steiner, David F.; van Boven, Hester; Vink, Robert; Hulsbergen-van de Kaa, Christina; van der Laak, Jeroen; Amin, Mahul B.; Evans, Andrew J.; van der Kwast, Theodorus; Allan, Robert; Humphrey, Peter A.; Grönberg, Henrik; Samaratunga, Hemamali; Delahunt, Brett; Tsuzuki, Toyonori; Häkkinen, Tomi; Egevad, Lars; Demkin, Maggie; Dane, Sohier; Tan, Fraser; Valkonen, Masi; Corrado, Greg S.; Peng, Lily; Mermel, Craig H.; Ruusuvuori, Pekka; Litjens, Geert; Eklund, Martin; Brilhante, Américo; Çakır, Aslı; Farré, Xavier; Geronatsiou, Katerina; Molinié, Vincent; Pereira, Guilherme; Roy, Paromita; Saile, Günter; Salles, Paulo G. O.; Schaafsma, Ewout; Tschui, Joëlle; Billoch-Lima, Jorge; Pereira, Emíio M.; Zhou, Ming; He, Shujun; Song, Sejun; Sun, Qing; Yoshihara, Hiroshi; Yamaguchi, Taiki; Ono, Kosaku; Shen, Tao; Ji, Jianyi; Roussel, Arnaud; Zhou, Kairong; Chai, Tianrui; Weng, Nina; Grechka, Dmitry (Nature Research, 2022)Through a community-driven competition, the PANDA challenge provides a curated diverse dataset and a catalog of models for prostate cancer pathology, and represents a blueprint for evaluating AI algorithms in digital ... -
Case report of a primary renal vein leiomyosarcoma
Yılmaz Erözbek, Sıla; Çakır, Aslı; Dervişoğlu, Sergülen (Springer, 2022)... -
Chordoid meningioma: Report of 5 cases and review of the literature
Tahta, Alican; Genç, Berkhan; Çakır, Aslı; Şekerci, Zeki (Taylor & Francis Ltd, 2023)Chordoid meningioma is a rare, more aggressive subtype of meningioma. This study documents the histological, radiological and clinical features of seven tumours in five patients among 131 meningioma patients who were treated ... -
Embryonic microenvironment suppresses YY1 and YY1-related genes in prostate cancer stem cells
Taşkıran, Ayşegül; Öktem, Gülperi; Demir, Aleyna; Oltulu, Fatih; Özçınar, Emine; Düzağaç, Fahriye; Güven, Ümmü; Karakoç, Emre; Çakır, Aslı; Ayla, Şule; Güven, Selçuk; Açıkgöz, Eda (2024)Yin yang 1 (YY1), a transcription factor, plays crucial roles in cell fate specification, differentiation, and pluripotency during embryonic development. It is also involved in tumorigenesis, drug resistance, metastasis, ... -
Evaluating the features of interdigital neuroma using 3-Tesla magnetic resonance imaging
Örmeci, Tuğrul; Güler, Olcay; Malkoç, Melih; Kaya, Nurullah; İşyar, Mehmet; Çakır, Aslı; Şen, Selva; Mahiroğulları, Mahir (Sociedad Anatómica Española, 2023)Interdigital neuroma is an entrapment neurop-athy of the interdigital nerve. Previously, studies on interdigital neuroma were done with 1 Tesla Magnetic Resonance Imaging and more often 1.5 Tesla Magnetic Resonance Imaging. ... -
Evaluation of pathologically confirmed benign inflammatory breast diseases using artificial intelligence on ultrasound images
Durur Subaşı, Irmak; Eren, Abdulkadir; Güngören, Fatma Zeynep; Basım, Pelin; Gezen, Fazlı Cem; Çakır, Aslı; Erol, Cengiz; Koska, İlker Özgür (Spanish Society of Senology and Breast Pathology, 2024)Objectives: It was aimed to use AI retrospectively to evaluate US images of pathologically confirmed benign inflammatory lesions, to compare the results of AI with our US reports, and to test the reliability of AI in itself. ... -
The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice
Bahhar, İlham; Eş, Zeynep; Köse, Oğuzhan; Turna, Akif; Günlüoğlu, Mehmet Zeki; Çakır, Aslı; Duralı, Deniz; Magnusson, Fay C. (Frontiers Media SA, 2023)Background: Group 2 innate lymphoid cells (ILC2) can be activated by interleukin (IL)-33 or IL-25. IL-25-activated ILC2 cells help protect the host against helminth infection while exacerbating allergic-like inflammation ... -
Intramedullary schwannoma of cervicomedullary junction: A case report
Tahta, Alican; Çetinkal, Ahmet; Çakır, Aslı; Şekerci, Zeki (Elsevier Masson s.r.l., 2022)Background: Intramedullary schwannomas of brain stem and spinal cord are extremely rare. In almost all cases, homogeneous, asymmetrical or circular intensive gadolinium enhancement has been demonstrated. However, no cases ... -
Lungbank: a novel biorepository strategy tailored for comprehensive multiomics analysis and p-medicine applications in lung cancer
Demircan Çeker, Dilek; Baysungur, Volkan; Evman, Serdar; Kolbaş, İlker; Gördebil, Abdurrahim; Nalbantoğlu, Sinem M.; Tambağ, Yusuf; Kaçar, Ömer; Midi, Ahmet; Aslanoğlu, Hatice; Kara, Nülüfer; Algan, Nilgün; Boyacıoğlu, Ayberk; Karademir Yılmaz, Betül; Şahin, Ali; Ülbeği Polat, Hivda; Şehitoğullari, Abidin; Çibikdiken, Ali Osman; Büyükyılmaz, Mücahit; Aydilek, İbrahim Berkan; Eneş, Abdulkerim; Küçüker, Sevde; Karakaya, Fatih; Boyacı, İhsan; Gümüş, Mahmut; Şenol, Onur; Öztuğ, Merve; Şaban, Evren; Soysal, Ömer; Büyükpınarbaşılı, Nur; Turna, Akif; Günlüoğlu, Mehmet Zeki; Çakır, Aslı; Tekin, Şaban; Tazebay, Uygar; Karadağ, Abdullah (2024)Background/aim: LUNGBANK was established as part of Project LUNGMARK, pioneering a biorepository dedicated exclusively to lung cancer research. It employs cutting-edge technologies to streamline the handling of biospecimens, ... -
New generation oral anticoagulant apixaban enhances embryo implantation by increasing integrin beta 3 expression in rats: A pilot study
Yıldırım Köpük, Şule; Özer, Nida; Çekmez, Yasemin; Çakır, Aslı; Gürkan, Kıran (Sociedade Brasileira Reproducao Assistida-Sbra, 2022)Objective: The first aim of this study was to investigate the effect of apixaban on endometrial receptivity via immunohistochemical investigation of integrin beta 3 expression in pregnant rats. The second aim was to compare ... -
Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder
Yiğit Kaya, Süreyya; Aşkın, Abdullah Emre; Bektaş, Şebnem; Çakır, Aslı; Gökmen Sevindik, Ömür (Elsevier Ltd, 2023)Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains an effective option for the treatment of intermediate and high-risk Acute myeloid leukemia (AML). Post-transplant lymphoproliferative disorder (PTLD) ... -
NTRK-rearranged spindle cell neoplasm: A case report
Yılmaz Erözbek, Sıla; Çakır, Aslı; Dervişoğlu, Sergülen (Springer, 2022)... -
Pretreatment platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a predictor of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: Single center experience from Turkey
Açıkgöz, Özgür; Yıldız, Anıl; Bilici, Ahmet; Ölmez, Ömer Fatih; Basım, Pelin; Çakır, Aslı (Lippincott Williams and Wilkins, 2022)The aim of this study was to investigate the predictive value of PLR and NLR as an indicator of pathological complete response (pCR) in patients with breast cancer after NACT. One hundred thirty-nine patients with early ... -
Primary leiomyosarcoma of the stomach: A case report
Özden, Ferhat; Çakır, Aslı (Springer, 2022)... -
Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes
Yıldız, Anıl; Bilici, Ahmet; Açıkgöz, Özgür; Hamdard, Jamshid; Basım, Pelin; Çakır, Tansel; Çakır, Aslı; Ölmez, Ömer Fatih; Gezen, Cem; Yıldız, Özcan (Taylor and Francis Ltd., 2024)The current study was designed to assess the response to treatment, as well as clinical and survival outcomes, across different breast cancer subtypes in patients who underwent neoadjuvant chemotherapy (NAC). From 2014 to ... -
Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer
Kutlu, Yasin; Çekin, Ruhper; Göktaş Aydın, Sabin; Shbair, Abdallah T. M.; Bilici, Ahmet; Arıcı, Serdar; Öven, Bala Başak; Açıkgöz, Özgür; Özcan, Erkan; Ölmez, Ömer Fatih; Çakır, Aslı; Şeker, Mesut (2024)Loss of human epidermal growth factor receptor 2 (HER2) expression can be seen in almost 25–30 % patients after HER2 receptor directed neoadjuvant treatment. These patients have unclear clinical outcomes in previous studies. ... -
Relationship between the change in tumour-infiltrating lymphocyte level and residual tumour after neoadjuvant chemotherapy in patients with locally advanced breast cancer
Erol, Vedat Buğra; Göktaş Aydın, Sabin; Bilici, Ahmet; Çakır, Aslı; Açıkgöz, Özgür; Ölmez, Ömer Fatih; Basım, Pelin (Taylor and Francis Ltd., 2023)To evaluate the tumour-infiltrating lymphocyte (TIL) rates in breast tissue before and after neoadjuvant chemotherapy (NAC) and their impact on survival, eighty-four patients with locally advanced breast cancer (LABC) were ...